According to a research paper published in the Asia Pacific Journal of Cancer, the Covid-19 pandemic has taken a big toll on the clinical trials running for oncology, the study and treatment of tumours.
The paper was titled ‘Covid-19 and Its Impact on Cancer Patient’s Outcome and Cancer Research’. It stated that the ongoing trials for the search of the potential vaccines for coronavirus have disrupted oncology trials.
The authors in the study cited reports that claimed there have been around 200 oncology trials that got suspended in March and April.
Researchers also noted that there are concerns regarding the investment opportunities for these trials.
According to the study, only one-fifth of institutions continue to enrol patients for research.
Cancer patients are more susceptible to infections due to their immunocompromised status, either due to disease or therapy, and subsequently, this may result in poor outcomes, especially in the case of